CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY Journal
Overview
publication venue for
- How I Treat Stage IV Non-Small Cell Lung Cancer in the Absence of Any Actionable Oncogenic Driver 2017
- HSP90 Inhibitors in Lung Cancer: Promise Still Unfulfilled. 14:346-356. 2016
- Targeted therapy vs chemotherapy: which has had more impact on survival in lung cancer? The significant impact of chemotherapy in lung cancer. 2014
- Highlights in NSCLC From the 2014 ASCO Meeting. 12:16-19. 2014
- Clinical roundtable monograph: Recent advances in taxanes for the first-line treatment of advanced non-small cell lung cancer. 2012
- Highlights in NSCLC From the 2012 American Society of Clinical Oncology Annual Meeting. 2012
- Highlights in NSCLC from the American Society of Clinical Oncology Meeting, June 3-7, 2011, Chicago, Illinois, USA. 2011
- Safety of capecitabine use in patients with liver dysfunction. 2007
- Update on nanoparticle albumin-bound paclitaxel. 2006
- Duration of therapy in advanced, metastatic non-small-cell lung cancer. 2003
Research
category
- ONCOLOGY Web of Science Category
Identity
International Standard Serial Number (ISSN)
- 1543-0790
Other
journal abbreviation
- CLIN ADV HEMATOL ONC
- Clin Adv Hematol Oncol